Ignite Creation Date:
2024-05-06 @ 4:08 PM
Last Modification Date:
2024-10-26 @ 2:04 PM
Study NCT ID:
NCT04887519
Status:
COMPLETED
Last Update Posted:
2023-04-18
First Post:
2021-05-13
Brief Title:
A Study of Brigatinib to Treat Adults With Anaplastic Lymphoma Kinase ALK Positive Metastatic Non Small Cell Lung Cancer NSCLC
Sponsor:
Takeda
Organization:
Takeda
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-31
Completion Date Type:
ACTUAL
First Submit Date:
2021-05-13
First Submit QC Date:
May 13 2021
Study First Post Date:
2021-05-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-14
Last Update Post Date:
2023-04-18
Last Update Post Date Type:
ACTUAL